絞り込み

18456

広告

ソフトバンクが配膳ロボットを発売 2021年1月に (財経新聞)

●飲食店で配膳・運搬を担うロボットを販売 ソフトバンクG傘下のソフトバンクロボティクスは28日、飲食店での配膳・運搬を担うロボット「Servi(サーヴィ)」を販...

  1. [企業] COVID-19入院患者へのC...
  2. 新型コロナ禍での緊急事態宣言には確かな効...
  3. [企業] 若年性特発性関節炎へのPfiz...
  4. 日本の「感染者バッシング」「マスク警察」...

ニュース一覧

「"Niegisch G "[Author]」の検索結果

101件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.

[Second-line treatment of metastatic urothelial carcinoma : Update immuno-oncology].

[Bladder cancer - complications related to urinary diversion].

Knockdown of UTX/KDM6A Enriches Precursor Cell Populations in Urothelial Cell Cultures and Cell Lines.

[Systemic therapy for metastatic urothelial carcinoma - Current status and what comes after checkpoint inhibitors?]

[Report from the 9th symposium of the German Association for Bladder Cancer Research].

Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells.

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation.

Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study.

Basic Hallmarks of Urothelial Cancer Unleashed in Primary Uroepithelium by Interference with the Epigenetic Master Regulator ODC1.

Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1.

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).

Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine?

Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.

Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.

Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary Database.

Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect.

Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
Sort by
※並べ替えは表示に時間がかかります